This Article Full Text Full Text (PDF) Supplemental Material Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schindowski, K. Articles by Buée, L. Search for Related Content PubMed PubMed Citation Articles by Schindowski, K. Articles by Buée, L.

(American Journal of Pathology. 2006;169:599-616.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.060002

Alzheimer’s Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits

Katharina Schindowski^*, Alexis Bretteville^*, Karelle Leroy, Séverine Bégard^*, Jean-Pierre Brion, Malika Hamdane^* and Luc Buée^*

From INSERM U815,^* Lille, France; the Faculté de Médecine, Institut de Médecine Prédictive et Recherche Thérapeutique, Université Lille 2, Lille, France; and the Laboratory of Histology and Neuropathology, Free University of Brussels, School of Medicine, Brussels, Belgium

Tau transgenic mice are valuable models to investigate the role of tau protein in Alzheimer’s disease and other tauopathies. However, motor dysfunction and dystonic posture interfering with behavioral testing are the most common undesirable effects of tau transgenic mice. Therefore, we have generated a novel mouse model (THY-Tau22) that expresses human 4-repeat tau mutated at sites G272V and P301S under a Thy1.2-promotor, displaying tau pathology in the absence of any motor dysfunction. THY-Tau22 shows hyperphosphorylation of tau on several Alzheimer’s disease-relevant tau epitopes (AT8, AT100, AT180, AT270, 12E8, tau-pSer396, and AP422), neurofibrillary tangle-like inclusions (Gallyas and MC1-positive) with rare ghost tangles and PHF-like filaments, as well as mild astrogliosis. These mice also display deficits in hippocampal synaptic transmission and impaired behavior characterized by increased anxiety, delayed learning from 3 months, and reduced spatial memory at 10 months. There are no signs of motor deficits or changes in motor activity at any age investigated. This mouse model therefore displays the main features of tau pathology and several of the pathophysiological disturbances observed during neurofibrillary degeneration. This model will serve as an experimental tool in future studies to investigate mechanisms underlying cognitive deficits during pathogenic tau aggregation.

This article has been cited by other articles:

				M.-M. Mocanu, A. Nissen, K. Eckermann, I. Khlistunova, J. Biernat, D. Drexler, O. Petrova, K. Schonig, H. Bujard, E. Mandelkow, et al. The Potential for -Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy J. Neurosci., January 16, 2008; 28(3): 737 - 748. [Abstract] [Full Text] [PDF]

				K. Eckermann, M.-M. Mocanu, I. Khlistunova, J. Biernat, A. Nissen, A. Hofmann, K. Schonig, H. Bujard, A. Haemisch, E. Mandelkow, et al. The beta-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy J. Biol. Chem., October 26, 2007; 282(43): 31755 - 31765. [Abstract] [Full Text] [PDF]

				K. Leroy, A. Bretteville, K. Schindowski, E. Gilissen, M. Authelet, R. De Decker, Z. Yilmaz, L. Buee, and J.-P. Brion Early Axonopathy Preceding Neurofibrillary Tangles in Mutant Tau Transgenic Mice Am. J. Pathol., September 1, 2007; 171(3): 976 - 992. [Abstract] [Full Text] [PDF]